Indications and uses
temporarily relieves minor aches and pains due to: headache muscular aches minor pain of arthritis toothache backache the common cold menstrual cramps temporarily reduces fever
temporarily relieves minor aches and pains due to: headache muscular aches minor pain of arthritis toothache backache the common cold menstrual cramps temporarily reduces fever
do not take more than directed the smallest effective dose should be used adults and children 12 years and older: take 1 caplet every 4 to 6 hours while symptoms persist if pain or fever does not respond to 1 caplet, 2 caplets may be used do not exceed 6 caplets in 24 hours, unless directed by a doctor children under 12 years: ask a doctor
Ibuprofen USP, 200mg (NSAID)*
*nonsteroidal anti-inflammatory drug
Pain reliever/fever reducer
*nonsteroidal anti-inflammatory drug
temporarily relieves minor aches and pains due to:
Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away.
Stomach bleeding warning: This product contains a nonsteroidal anti-inflammatory drug (NSAID), which may cause severe stomach bleeding. The chance is higher if you
Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.
take with food or milk if stomach upset occurs
you experience any of the following signs of stomach bleeding:
you have symptoms of heart problems or stroke:
If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use ibuprofen during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
carnauba wax, colloidal silicon dioxide, corn starch, FD&C yellow #6 aluminum lake, hypromellose, lactose anhydrous, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, sodium starch glycolate, stearic acid, titanium dioxide
Call 1-888-952-0050
Monday through Friday 9AM – 5PM EST
| Class | Version | Type | Effective |
|---|---|---|---|
| IBUPROFEN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| 16cde546-8deb-4df2-a072-dab5566ede95 | Product name | 1 | 20231003 |
| f6d1b8d7-3bd1-4248-eddd-b60565c88015 | Product name | 4 | 20230808 |
| 874f4e63-49d2-5150-5d77-052172814ebd | Product name | 6 | 20230105 |
| 557673c2-8256-b351-e863-4ec71a5a64b0 | Product name | 2 | 20160714 |
| dbc9a339-6215-4e94-9546-57a3b34902ce | Product name | 1 | 20160517 |
| 61c18d4e-b552-5478-8fc0-df38b93e3100 | Product name | 1 | 20140508 |
| 7b2938c9-7eb7-e312-ae90-f54f4240361e | Product name | 1 | 20140508 |
| 997601aa-bb5f-6971-6b90-a21132c12c7b | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69168-390-30 | Ibuprofen 200mg | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 1 | |
| 69168-390-30 | Ibuprofen 200mg | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69168-390 | 69168-390-30 |
Every source-derived ingredient row is available through these pages.
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077349-001 | IBUPROFEN | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A077349-001 | IBUPROFEN | 200MG | TABLET / ORAL | RS | 2005-06-21 | 3bdfa0b2c4d7… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen 200mg | IBUPROFEN 200MG | Allegiant Health | 51e95588-39af-40d6-9924-e98d42af15b9 | 2018-12-31 | Warnings | 69168-390-30 69168-390 69168039030 9d7fe948-b8c9-4798-b9bf-0cedd86f069b 51e95588-39af-40d6-9924-e98d42af15b9 |
Adverse event summaries are temporarily unavailable. Other product information remains available.